Showing 12,901 - 12,920 results of 39,181 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 1.17s Refine Results
  1. 12901
  2. 12902
  3. 12903

    Dung Beetles along a Tropical Altitudinal Gradient: Environmental Filtering on Taxonomic and Functional Diversity by Cássio Alencar Nunes (2852327)

    Published 2016
    “…The altitudinal gradient ranged from 800 up to 1400 m a.s.l. and we collected dung beetles at every 100 m of altitude. …”
  4. 12904
  5. 12905
  6. 12906
  7. 12907

    Presentation 1_Case Report: Full recovery in severe ParvovirusB19 myocarditis with DCM phenotype: the impact of rASD and PAB.pptx by T. Logeswaran (21495341)

    Published 2025
    “…The pressure gradient across the PAB ranged from 40 to 45 mmHg, and LVEDD decreased to a mean z-score of +3.5. Within three to six months, LVEDD normalized, and LV-EF increased to a mean of 63% (range: 57%–68%). …”
  8. 12908
  9. 12909
  10. 12910

    Table_1_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2019
    “…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
  11. 12911

    Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2019
    “…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
  12. 12912

    Table_2_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2022
    “…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
  13. 12913

    Table_1_Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.do... by Roger H. Kobayashi (6291587)

    Published 2022
    “…The incidence of site reactions decreased with successive infusions.</p><p>Conclusion: The new 16.5% SCIG octanorm was shown to be efficacious in preventing infections in PIDs, and was well tolerated.…”
  14. 12914
  15. 12915

    Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts - Fig 2 by Sunil C. Kaul (186002)

    Published 2016
    “…<p>(<b>A</b>) Hydroponic cultivation system for Ashwagandha and (<b>B)</b> hydroponically grown leaves are shown. …”
  16. 12916

    In 5-HTT-/- mice subjected to the WM a low number of NeuroD positive cells is correlated with a poor performance in the Morris water maze. by Margherita M. Karabeg (475186)

    Published 2013
    “…<p>Applying the Spearman`s test in the quantitative immunohistochemistry study revealed a linear dependence between the learning performance (decreasing learning performance is expressed as increasing area under the learning curve; AuC) and the number of NeuroD-immunoreactive (ir) cells could be found in the temporal hippocampus of 5-HTT-/- WM mice. …”
  17. 12917
  18. 12918
  19. 12919

    FIGURE 5 from Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ Signaling by Zhuo-Ying Tao (17971607)

    Published 2024
    “…<b>B–F,</b> The expression levels of β3-tubulin, Ki-67, caspase-3, TGFβ1, and PD-L1 in each group [each bar represents mean ± SD (<i>n</i> = 5–7); ***, <i>P</i> < 0.001 versus MOC1+IgG; <sup>###</sup>, <i>P</i> < 0.001 vs. …”
  20. 12920